Additionally, to confirm that the CM we had manufactured produces substantial amounts of C5a and targets W54011, we purchased recombinant C5a and processed it with three GBM tumorspheres (TS15-88, TS14-15, and U87). The gene discussed is C5; the disease is glioblastoma.